Last reviewed · How we verify

losartan + hydrochlorothiazide, if necessary

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · Phase 3 active Small molecule

Losartan is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to relax blood vessels and lower blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases urine production to reduce blood pressure.

Losartan is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to relax blood vessels and lower blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases urine production to reduce blood pressure. Used for Hypertension, Chronic kidney disease.

At a glance

Generic namelosartan + hydrochlorothiazide, if necessary
SponsorDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Drug classAngiotensin II receptor antagonist and thiazide diuretic
TargetAngiotensin II receptor
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

Losartan works by blocking the angiotensin II receptor, which is part of the renin-angiotensin-aldosterone system (RAAS) that regulates blood pressure. By blocking this receptor, losartan prevents the vasoconstriction and fluid retention caused by angiotensin II, leading to a decrease in blood pressure. Hydrochlorothiazide, on the other hand, increases urine production by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule, which leads to a decrease in fluid volume and a subsequent decrease in blood pressure.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results